Bruce C. Conway
Direttore/Membro del Consiglio presso Trigemina, Inc.
Posizioni attive di Bruce C. Conway
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Bruce C. Conway
Precedenti posizioni note di Bruce C. Conway
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CLEARPOINT NEURO, INC. | Direttore/Membro del Consiglio | 01/05/2011 | 12/04/2013 |
| Independent Dir/Board Member | 01/05/2011 | 12/04/2013 | |
Whitehall Corp.
 Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 3 |
| Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Whitehall Corp.
Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Electronic Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Health Technology |
- Borsa valori
- Insiders
- Bruce C. Conway
- Esperienza
